TrialBritish journal of haematology2016

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma.

Scott D Ramsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.